MyAverix Finance
VI · Healthcare
Valneva SE (VLA)
Biotechnology
Valneva SE (VLA) is listed on VI in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $473.17M, P/E ratio is 25.00, net margin is -88.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VLA
Valneva SE (VLA) — FAQ
What is Valneva SE's market cap?
Valneva SE (VLA) has a reported market cap of $473.17M (data as of 2026-05-24).
What is VLA's P/E ratio?
The price-to-earnings (P/E) ratio for Valneva SE (VLA) is 25.00 (data as of 2026-05-24).
Does Valneva SE pay a dividend?
Dividend yield is not available in the current snapshot for Valneva SE (VLA). Check the MyAverix Finance app for the latest dividend data.
What sector is Valneva SE in?
Valneva SE (VLA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VLA listed on?
VLA is listed on VI.
What is Valneva SE's net margin?
Valneva SE (VLA) reports a net margin of -88.3% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.